An AI lesson from history
This time last year DDW was reflecting upon the drug discovery and development sector’s push towards artificial intelligence (AI), in particular generative AI and how it could inform research. Within that article included the news of BenevolentAI’s disappointing results of its Phase II clinical trial of its atopic dermatitis drug… Read More